Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Viridian Therapeutics Inc (VRDN)

Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,493,435
  • Shares Outstanding, K 63,822
  • Annual Sales, $ 310 K
  • Annual Income, $ -237,730 K
  • 60-Month Beta 1.08
  • Price/Sales 4,732.74
  • Price/Cash Flow N/A
  • Price/Book 4.63
Trade VRDN with:

Options Overview Details

View History
  • Implied Volatility 55.70% ( -3.36%)
  • Historical Volatility 96.95%
  • IV Percentile 7%
  • IV Rank 16.74%
  • IV High 193.07% on 08/13/24
  • IV Low 28.08% on 05/22/24
  • Put/Call Vol Ratio 0.66
  • Today's Volume 123
  • Volume Avg (30-Day) 1,247
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 14,369
  • Open Int (30-Day) 19,170

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -1.11
  • Number of Estimates 7
  • High Estimate -1.05
  • Low Estimate -1.17
  • Prior Year -1.09
  • Growth Rate Est. (year over year) -1.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.12 +50.59%
on 09/10/24
24.75 -8.00%
on 10/03/24
+8.58 (+60.47%)
since 09/09/24
3-Month
12.04 +89.12%
on 07/10/24
24.75 -8.00%
on 10/03/24
+10.43 (+84.52%)
since 07/09/24
52-Week
10.93 +108.42%
on 10/25/23
24.75 -8.00%
on 10/03/24
+8.93 (+64.52%)
since 10/09/23

Most Recent Stories

More News
Stocks Recover Early Losses and Close Higher as Chip Stocks Surge

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up by +1.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +2.17%. Stocks...

$SPX : 5,792.04 (+0.71%)
SPY : 577.14 (+0.69%)
$DOWI : 42,512.00 (+1.03%)
DIA : 425.05 (+1.01%)
$IUXX : 20,268.86 (+0.80%)
QQQ : 493.15 (+0.79%)
ZNZ24 : 112-045 (-0.06%)
ARM : 148.43 (+3.36%)
NVDA : 132.65 (-0.18%)
AVGO : 185.95 (+2.89%)
ASML : 845.90 (+2.63%)
KLAC : 804.63 (+2.64%)
Stocks Move Higher After Today's CPI Report

The S&P 500 Index ($SPX ) (SPY ) today is up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +1.52%. After starting the day in...

$SPX : 5,792.04 (+0.71%)
SPY : 577.14 (+0.69%)
$DOWI : 42,512.00 (+1.03%)
DIA : 425.05 (+1.01%)
$IUXX : 20,268.86 (+0.80%)
QQQ : 493.15 (+0.79%)
ZNZ24 : 112-045 (-0.06%)
DFS : 143.15 (+0.75%)
COF : 151.80 (+1.54%)
RF : 23.08 (+1.50%)
CFG : 41.47 (+0.63%)
CINF : 134.69 (+0.61%)
Stocks Undercut as US Core Inflation Fails to Decline

The S&P 500 Index ($SPX ) (SPY ) today is down by -0.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -1.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.19%. Stocks are under...

$SPX : 5,792.04 (+0.71%)
SPY : 577.14 (+0.69%)
$DOWI : 42,512.00 (+1.03%)
DIA : 425.05 (+1.01%)
$IUXX : 20,268.86 (+0.80%)
QQQ : 493.15 (+0.79%)
ZNZ24 : 112-045 (-0.06%)
NVDA : 132.65 (-0.18%)
ASML : 845.90 (+2.63%)
ARM : 148.43 (+3.36%)
MRVL : 72.84 (-0.37%)
MU : 101.70 (-0.82%)
3 Top Small-Cap Tech Picks for Investors This Month

Wall Street believes these three small companies have significant upside potential.

AMZN : 185.17 (+1.34%)
MSFT : 417.46 (+0.66%)
NVDA : 132.65 (-0.18%)
CHPT : 1.3700 (-1.44%)
$SPX : 5,792.04 (+0.71%)
VRDN : 22.77 (-2.69%)
SLNO : 51.08 (-1.71%)
2 Growth Stocks Wall Street Analysts Think Can Double in Value

Is now a good time to buy these promising healthcare stocks?

VRDN : 22.77 (-2.69%)
DNA : 7.91 (-5.16%)
Why Shares of Viridian Therapeutics Are Falling Tuesday

The company announced preliminary trial results for its lead therapy.

HZNP : 116.30 (+0.04%)
VRDN : 22.77 (-2.69%)
Why These 2 Nasdaq Biotech Stocks Fell Hard Tuesday Morning

Broader markets seemed likely to start out on a positive note despite these two outliers.

COMP : 5.64 (-1.74%)
$NASX : 18,291.62 (+0.60%)
VRDN : 22.77 (-2.69%)
IOVA : 9.61 (-1.13%)
Viridian Therapeutics (NASDAQ: VRDN) Shares Positive Clinical Data from Phase 1/2 Trial of VRDN-001 for Treatment of Thyroid Eye Disease

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is engaged as a biotechnology company, which is focused on the research and development of

VRDN : 22.77 (-2.69%)
Bed Bath & Beyond Leads Meme Stocks, But Here's Monday's Big Stock Winner

In a dour market open, here's why these stocks are on the rise.

COMP : 5.64 (-1.74%)
$DOWI : 42,512.00 (+1.03%)
$SPX : 5,792.04 (+0.71%)
$NASX : 18,291.62 (+0.60%)
BBBY : 0.0751 (-27.09%)
VRDN : 22.77 (-2.69%)
Viridian Therapeutics to Report Second Quarter 2022 Financial Results and Host Conference Call on August 15, 2022

WALTHAM, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company advancing new treatments for...

VRDN : 22.77 (-2.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Viridian Therapeutics Inc. is a biotechnology company advancing new treatments for patients suffering from serious diseases. The company's program includes VRDN-001, which is in clinical stage. Viridian Therapeutics Inc., formerly known as miRagen Therapeutics Inc., is based in BOULDER, Colo.

See More

Key Turning Points

3rd Resistance Point 24.52
2nd Resistance Point 24.01
1st Resistance Point 23.39
Last Price 22.77
1st Support Level 22.26
2nd Support Level 21.75
3rd Support Level 21.13

See More

52-Week High 24.75
Last Price 22.77
Fibonacci 61.8% 19.47
Fibonacci 50% 17.84
Fibonacci 38.2% 16.21
52-Week Low 10.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar